The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis, according ...

ASTCT Update is sponsored by American Society for Transplantation and Cellular Therapy, which is dedicated to the application and success of blood and marrow transplantation and related cellular ...